Kick off an exceptional day of learning by joining Psych Congress Regionals expert faculty for a brief roundtable discussion about the state of mental healthcare – what’s here, what’s new, and what’s next. Gain unique perspectives on everything from disease-states to the work-life-balance of today’s clinicians and blooming opportunities in treatment.

Attention-Deficit/Hyperactivity Disorder (ADHD) is no longer viewed solely as a childhood condition, yet its identification and management in adults remain challenging. This session will provide psychiatric professionals with cutting-edge insights into ADHD across the lifespan, focusing on the nuances of diagnosing and treating the condition in adults while considering its developmental trajectory from childhood. By bridging gaps in care and integrating evolving perspectives, this session aims to equip clinicians with actionable tools to enhance their practice and provide comprehensive support to patients with ADHD at every stage of life.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Schizophrenia is a serious mental illness affecting 1-2% of the United States (US) population, impairing cognition, social function, and quality of life while increasing the risk of early death. It involves positive symptoms (hallucinations, delusions), negative symptoms (lack of motivation, reduced speech), and cognitive deficits, typically emerging in adolescence or early adulthood. Early diagnosis and timely treatment remain key to improving outcomes and long-term recovery. Standard antipsychotics target dopamine and serotonin receptors but provide limited relief for negative and cognitive symptoms. Newer and emerging treatments, however, like muscarinic acetylcholine receptor modulators, offer a promising alternative. They include KarXT (Xanomeline-Trospium), which was FDA-approved in September 2024, as well as emraclidine and NBI-1117568, which are in late-stage trials. These therapies shift treatment away from dopamine blockade toward muscarinic receptor activation, potentially addressing more symptoms. As these innovations become available in clinical practice, psychiatry and mental health professionals must stay informed about their mechanisms of action, clinical data, and best use in patient care.

Women’s reproductive health plays a profound yet often underrecognized role in shaping mental well-being. This session will explore the intricate connections between hormonal changes, reproductive milestones, and psychiatric outcomes in women.

Join expert panelists from sessions throughout this section of the day as they answer your most pressing and popular questions from sessions so far.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Excessive daytime sleepiness (EDS) and obstructive sleep apnea (OSA) are frequently overlooked contributors to poor psychiatric outcomes, compounding cognitive, mood, and functional impairments. This session will explore the high prevalence of EDS and its psychiatric comorbidities, underscoring the critical role of psychiatry clinicians in recognizing and addressing these sleep-related conditions. Attendees will gain practical strategies to identify EDS, screen for underlying OSA, and initiate timely referrals to sleep specialists. The session will also examine emerging treatments for EDS and OSA, including novel and investigational agents, offering insight into how they compare with traditional therapies and their potential to enhance psychiatric care.

Supported by an educational grant from Axsome Therapeutics, Inc.

Developed in partnership with the Sleep Research Society Foundation.

Join expert panelists from sessions throughout this section of the day as they answer your most pressing and popular questions from sessions so far.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

Dive into real-world, complex clinical cases in this panel discussion among our experts. In this two-part session, Dr. Rakesh Jain will share four real-world examples of clinical cases with our faculty members and will discuss the challenges and most effective approaches to each. In the first half of the session, Dr. Jain will be joined by experts from the Psych Congress Steering Committee as we explore the cases.

Close out an exceptional day of learning by joining Psych Congress Regionals expert faculty for a brief roundtable discussion about the state of mental healthcare – what’s here, what’s new, and what’s next. Gain unique perspectives on everything from disease-states to the work-life-balance of today’s clinicians and blooming opportunities in treatment.

Kick off an exceptional day of learning by joining Psych Congress Regionals expert faculty for a brief roundtable discussion about the state of mental healthcare – what’s here, what’s new, and what’s next. Gain unique perspectives on everything from disease-states to the work-life-balance of today’s clinicians and blooming opportunities in treatment.

Insomnia is a pervasive issue in psychiatric practice, often intertwined with mood disorders, anxiety, and other mental health conditions. This expert panel discussion will explore the complexities of diagnosing insomnia, utilizing screening tools to assess psychiatric comorbidities, and determining the most effective treatment strategies. The discussion will also address emerging research, practical challenges in clinical practice, and strategies for integrating evidence-based care into real-world settings.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.

This presentation will begin by describing common age-related changes in both brain and mind and how they affect our daily life in both positive and negative ways. Neuronal aging does exact a toll on overall neurocognitive abilities, but the aging brain is also able to compensate in surprising ways that actually offer several advantages. Emergent strengths that counterbalance declines in short-term memory, processing speed and multi-tasking include wisdom, resilience, purpose and creativity. The talk will outline each one and present an overall approach to identifying and leveraging them in clinical work.

Join expert panelists from sessions throughout this section of the day as they answer your most pressing and popular questions from sessions so far.

Innovation Theaters are informational sessions designed to complement your educational experience by further enhancing your knowledge and confidence of disease states or products. No CE credits are offered at these programs.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.

Psychedelics are redefining the landscape of psychiatric care, offering promising interventions for conditions like depression, PTSD, and addiction. This session will provide an in-depth exploration of emerging research on compounds such as ibogaine, 5-MeO-DMT, and DMT, as well as data from leading clinical trials. Attendees will gain practical insights into the expanding therapeutic potential of psychedelics beyond major depressive disorder, including their applications in treating substance use disorders and generalized anxiety. The session will also address the growing divide between medical, personal, and decriminalized uses of psychedelics, equipping clinicians with the knowledge to navigate this evolving field responsibly and effectively.

Join expert panelists from sessions throughout this section of the day as they answer your most pressing and popular questions from sessions so far.

Dive into real-world, complex clinical cases in this panel discussion among our experts. In this two-part session, Dr. Rakesh Jain will share four real-world examples of clinical cases with our faculty members and will discuss the challenges and most effective approaches to each. In the first half of the session, Dr. Jain will be joined by experts from the Psych Congress Steering Committee as we explore the cases.

Close out an exceptional day of learning by joining Psych Congress Regionals expert faculty for a brief roundtable discussion about the state of mental healthcare – what’s here, what’s new, and what’s next. Gain unique perspectives on everything from disease-states to the work-life-balance of today’s clinicians and blooming opportunities in treatment.